Stock Snapshot
Price Performance
Recommendation Rationale
Favorable growth outlook supported by strategic acquisition and margin expansion potential.
Basis of our Recommendation
IKS is poised for significant growth driven by the strategic acquisition of TruBridge, which is anticipated to enhance both growth potential and margins. While there are initial concerns regarding dilution, the overall outlook remains positive, supported by strong operational capabilities.
Why We Like This Stock
- Acquisition of TruBridge expected to enhance growth potential
- Anticipated margin expansion from the acquisition
- Strong operational capabilities to support growth
Things To Watch Out For
- Initial dilution concerns related to the acquisition
Key Parameters
Financial Snapshot
| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 1,818 | 2,664 | 3,194 | 4,217 | 5,090 |
| Profit Before Tax (Cr.) | 442 | 604 | 905 | 1,183 | 1,469 |
| PBT Margin | 24.3% | 22.7% | 28.3% | 28.1% | 28.9% |
| Net Profit (Cr.) | 351 | 480 | 705 | 924 | 1,148 |
| EPS | 20.5 | 28.0 | 41.2 | 54.0 | 67.1 |
Company Overview
Show Company Profile
Inventurus Knowledge Solutions Limited operates as a technology-enabled healthcare solutions provider. The company offers a care enablement platform that assists physician businesses in outpatient and inpatient care activities in the United States, Canada, and Australia. The company offers a platform that serves healthcare organizations, including health systems/ integrated delivery networks, academic medical centers, multi-specialty medical groups, single-specialty medical groups, ancillary healthcare organizations, and other outpatient healthcare delivery organizations. Inventurus Knowledge Solutions Limited was incorporated in 2006 and is based in Navi Mumbai, India.